A detailed history of Fieldpoint Private Securities, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Fieldpoint Private Securities, LLC holds 20 shares of HAE stock, worth $1,757. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20
Previous 85 76.47%
Holding current value
$1,757
Previous $5,000 80.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

SELL
$49.27 - $66.08 $3,202 - $4,295
-65 Reduced 76.47%
20 $1,000
Q1 2022

Apr 07, 2022

BUY
$43.77 - $63.22 $3,720 - $5,373
85 New
85 $5,000
Q3 2021

Nov 12, 2021

SELL
$57.6 - $70.59 $1,152 - $1,411
-20 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$51.81 - $118.56 $1,813 - $4,149
-35 Reduced 63.64%
20 $1,000
Q4 2020

Jan 28, 2021

BUY
$88.75 - $119.95 $4,881 - $6,597
55 New
55 $7,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.51B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Fieldpoint Private Securities, LLC Portfolio

Follow Fieldpoint Private Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fieldpoint Private Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fieldpoint Private Securities, LLC with notifications on news.